BioMarin Genetics definition

BioMarin Genetics means BioMarin Genetics, Inc., a Delaware corporation and wholly-owned subsidiary of BioMarin.

Examples of BioMarin Genetics in a sentence

  • The Joint Venture is owned: • 50% by BioMarin Pharmaceutical Inc., which is referred to as BioMarin, and BioMarin Genetics, Inc., a wholly-owned subsidiary of BioMarin.

  • The Joint Venture is owned: •50% by BioMarin Pharmaceutical Inc., which is referred to as BioMarin, and BioMarin Genetics, Inc., a wholly-owned subsidiary of BioMarin.

  • BioMarin is the sole initial member of BioMarin/Genzyme LLC and, immediately following the execution and delivery of this Agreement, will transfer and assign one percent (1%) of its interest to BioMarin Genetics, and BioMarin Genetics will be admitted as a member of BioMarin/Genzyme LLC.

  • Delaware 100% -------------------------------------------- ------------------------------------ --------------------------- BioMarin Genetics Inc.

  • Other than BioMarin Genetics, the Corporation does not otherwise own or control, directly or indirectly, any other corporation, association or business entity.

  • The Company has no subsidiaries or affiliated ------------ companies other than: (i) Glyko, Inc., (ii) BioMarin Genetics, Inc., and (iii) BioMarin/Genzyme LLC.

  • BioMarin Genetics is validly existing under, and by virtue of the laws of the State of Delaware and is in good standing under such laws.

  • BioMarin Genetics has the requisite corporate power to own and operate its property and assets and to carry on its business as presently conducted.

  • In connection with the transactions contemplated by the Collaboration Agreement between the Corporation and Purchaser, of even date herewith, the Corporation has caused to be incorporated in Delaware a wholly-owned subsidiary, BioMarin Genetics, Inc.

  • The proposed child care center is a conditionally permitted use in the Mixed-Use Zoning District and complies with the applicable development standards as cited in Table 4.

Related to BioMarin Genetics

  • Merck has the meaning set forth in the preamble.

  • BMS means the Company, all related companies, affiliates, subsidiaries, parents, successors, assigns and all organizations acquired by the foregoing.

  • Novartis shall have the meaning set forth in the Preamble.

  • Lilly has the meaning set forth in the Preamble.

  • Elan means Elan Corp and its Affiliates.

  • GSK will have the meaning set forth in the Preamble.

  • Manufacturing Technology means any and all patents, patent applications, Know-How, and all intellectual property rights associated therewith, and including all tangible embodiments thereof, that are necessary or useful for the manufacture of adeno- associated viruses, adeno-associated virus vectors, research or commercial reagents related thereto, Licensed Products, or other products, including manufacturing processes, technical information relating to the methods of manufacture, protocols, standard operating procedures, batch records, assays, formulations, quality control data, specifications, scale up, any and all improvements, modifications, and changes thereto, and any and all activities associated with such manufacture. Any and all chemistry, manufacturing, and controls (CMC), drug master files (DMFs), or similar materials provided to regulatory authorities and the information contained therein are deemed Manufacturing Technology.

  • Pfizer shall have the meaning set forth in the preamble.

  • DSM means the most current edition of the Diagnostic and Statistical Manual of Mental Disorders published by the American Psychiatric Association.

  • CTI means CTI Logistics Limited (ABN 69 008 778 925) and/or any Affiliate of CTI Logistics Limited as the case may be, which performs all or any of the Services.

  • ISIS means the department’s individualized services information system.

  • Siemens means Siemens AG (Germany) and its Affiliates.

  • GTC means General Terms & Conditions of Contract.

  • Bioassay means the determination of kinds, quantities or concentrations and, in some cases, the locations of radioactive material in the human body, whether by direct measurement, in vivo counting, or by analysis and evaluation of materials excreted or removed from the human body. For purposes of these rules, “radiobioassay” is an equivalent term.

  • PTC means the tax credit for electricity produced from certain renewable generation resources described in Section 45 of the Internal Revenue Code of 1986, as it may be amended or supplemented from time to time.

  • API means the American Petroleum Institute.

  • Shire means Shire of Augusta Margaret River

  • NPS means nominal pipe size.

  • IDT means intradepartmental transfer.

  • CMC means Comprehensive maintenance Contract (labour, spare and preventive maintenance)

  • DS Electric generation service that is provided at retail pursuant to the Applicable Legal Authorities under the Company’s retail electric tariffs and under any other agreements or arrangements between the Company and Customers, to any Customer that is not being served by an EGS. Default Allocation Assessment – shall have the meaning ascribed to it under the PJM Agreements. Delivery Period – The delivery period specified in an Appendix C Transaction Confirmation. Delivery Point – Means the applicable zone of the Company as designated by PJM. DS Customer(s) – Retail customers who are provided Default Service pursuant to the terms of this Agreement, the Applicable Legal Authorities and the Company’s retail tariffs.

  • Collaboration Technology means the Collaboration Know-How and the Collaboration Patents.

  • Collaborative drug therapy management means participation by an authorized pharmacist and a physician in the management of drug therapy pursuant to a written community practice protocol or a written hospital practice protocol.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Biomarker means a parameter or characteristic in a patient or Patient Sample, the measurement of which is useful (a) for purposes of selecting appropriate therapies or patient populations or monitoring disease susceptibility, severity or state, or monitoring therapies for such patient and/or (b) for predicting the outcome of a particular treatment of such patient.

  • in vitro diagnostic medical device means any medical device which is a reagent, reagent product, calibrator, control material, kit, instrument, apparatus, equipment, software or system, whether used alone or in combination, intended by the manufacturer to be used in vitro for the examination of specimens, including blood and tissue donations, derived from the human body, solely or principally for the purpose of providing information: